ironweed and Reduced Relapse Rate

Time to effect

Median: 5.6 months · IQR 5.6 months–5.6 months · Range 5.6 months–5.6 months — Reported in 1 of 1 study

Safety in these studies

drowsinessIncreased risk16.67% vs 90.48%, P<0.001
dry mouth and drowsiness were greater found in nortriptyline group (35.71% vs 90.48%, P<0.001 and 16.67% vs 90.48%, P<0.001, respectively)
from: Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Co
dry mouthIncreased risk35.71% vs 90.48%, P<0.001
dry mouth and drowsiness were greater found in nortriptyline group (35.71% vs 90.48%, P<0.001 and 16.67% vs 90.48%, P<0.001, respectively)
from: Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Co
tongue bitter taste or numbnessIncreased risk61.9% vs 30.95%, P=0.004
adverse events including tongue bitter taste or numbness were found in VC group to be greater than in nortriptyline group (61.9% vs 30.95%, P=0.004)
from: Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Co
Overall tolerabilityReported
Serious adverse events were not found.
from: Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Co

1 of 1 paper

Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Controlled Trial.